Literature DB >> 20854379

A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland.

K N Barnett1, S A Ogston, M E T McMurdo, A D Morris, J M M Evans.   

Abstract

AIMS: To determine absolute and relative risks of all-cause and cardiovascular mortality among patients newly diagnosed with Type 2 diabetes.
METHODS: In an observational cohort study using record-linkage databases, based in Tayside, Scotland, UK, we identified newly diagnosed patients with Type 2 diabetes in 1993-2004. We also identified a set of non-diabetic comparators from lists of patients registered with a general practice, individually matched to the diabetic patients by sex, age and deprivation. We followed up patients for mortality and cardiovascular mortality over a 12-year period and calculated hazard ratios using Cox regression.
RESULTS: There were 10,532 patients with Type 2 diabetes and 21,056 non-diabetic comparators. Diabetic patients in every age/sex group had higher absolute mortality rates. Even taking deprivation into account, the hazard ratio for mortality was 1.32 (95% CI 1.25-1.40), decreasing to 1.15 (1.09-1.22) after adjusting for pre-existing cardiovascular disease. The hazard ratios for cardiovascular mortality were higher, decreasing from 1.51 (1.37-1.67) to 1.23 (1.11-1.36) after adjusting for pre-existing cardiovascular disease. The hazard ratios decreased with increasing age at diagnosis, although the difference in absolute rate of mortality increased slightly with age. Increased mortality risks were only evident 2 years after diagnosis and increased thereafter.
CONCLUSIONS: Patients with Type 2 diabetes have an increased risk of all-cause and cardiovascular mortality compared with non-diabetic comparators, although this is not observable immediately after diagnosis. Age at diagnosis and duration of the disease independently affect absolute and relative mortality risk.
© 2010 The Authors. Diabetic Medicine © 2010 Diabetes UK.

Entities:  

Mesh:

Year:  2010        PMID: 20854379     DOI: 10.1111/j.1464-5491.2010.03075.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  32 in total

1.  Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men.

Authors:  A J Ahola; V Harjutsalo; M Saraheimo; C Forsblom; P-H Groop
Journal:  Diabetologia       Date:  2011-10-28       Impact factor: 10.122

2.  Hip strength: ankle proprioceptive threshold ratio predicts falls and injury in diabetic neuropathy.

Authors:  James K Richardson; Trina Demott; Lara Allet; Hogene Kim; James A Ashton-Miller
Journal:  Muscle Nerve       Date:  2014-01-20       Impact factor: 3.217

Review 3.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

4.  Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study.

Authors:  Manuel A Gomez-Marcos; Jose I Recio-Rodríguez; Maria C Patino-Alonso; Cristina Agudo-Conde; Leticia Gomez-Sanchez; Emiliano Rodriguez-Sanchez; Marta Gomez-Sanchez; Luis Garcia-Ortiz
Journal:  Cardiovasc Diabetol       Date:  2011-10-14       Impact factor: 9.951

5.  The excess mortality risk of diabetes associated with functional decline in older adults: results from a 7-year follow-up of a nationwide cohort in Taiwan.

Authors:  Chia-Lin Li; Hsing-Yi Chang; Yea-Ing L Shyu
Journal:  BMC Public Health       Date:  2011-12-23       Impact factor: 3.295

6.  Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine.

Authors:  Sorin Ioacara; Cristian Guja; Aura Reghina; Sorina Martin; Anca Sirbu; Simona Fica
Journal:  J Diabetes Res       Date:  2015-06-14       Impact factor: 4.011

7.  Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study.

Authors:  Manuel Ángel Gómez-Marcos; José Ignacio Recio-Rodríguez; Leticia Gómez-Sánchez; Cristina Agudo-Conde; Emiliano Rodríguez-Sanchez; JoseAngel Maderuelo-Fernandez; Marta Gomez-Sanchez; Luís García-Ortiz
Journal:  Cardiovasc Diabetol       Date:  2015-10-01       Impact factor: 9.951

8.  All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database.

Authors:  Kathryn S Taylor; Carl J Heneghan; Andrew J Farmer; Alice M Fuller; Amanda I Adler; Jeffrey K Aronson; Richard J Stevens
Journal:  Diabetes Care       Date:  2013-02-22       Impact factor: 19.112

9.  Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes--a prospective observational cohort study.

Authors:  Elsa M Dahlén; Niclas Bjarnegård; Toste Länne; Fredrik H Nystrom; Carl J Ostgren
Journal:  Cardiovasc Diabetol       Date:  2013-03-28       Impact factor: 9.951

10.  Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies.

Authors:  Elin Olafsdottir; Thor Aspelund; Gunnar Sigurdsson; Rafn Benediktsson; Bolli Thorsson; Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Vilmundur Gudnason
Journal:  BMC Public Health       Date:  2013-01-15       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.